Rhenman & Partners Asset Management AB boosted its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 7.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 750,000 shares of the medical equipment provider’s stock after purchasing an additional 50,000 shares during the period. Boston Scientific accounts for 4.3% of Rhenman & Partners Asset […]
Equities researchers at The Goldman Sachs Group assumed coverage on shares of Boston Scientific (NYSE:BSX – Get Free Report) in a research note issued to investors on Thursday, Marketbeat.com reports. The firm set a “buy” rating and a $90.00 price target on the medical equipment provider’s stock. The Goldman Sachs Group’s target price would indicate […]
Boston Scientific Co. (NYSE:BSX – Get Free Report) EVP Arthur C. Butcher sold 14,011 shares of the stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $75.34, for a total transaction of $1,055,588.74. Following the transaction, the executive vice president now owns 20,197 shares in the company, […]
Parnassus Investments LLC raised its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 26.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,711 shares of the medical equipment provider’s stock after acquiring an additional 2,038 shares during the quarter. Parnassus […]